Finance

Lists
Why is BRTX down ५.६६%?
Dive Deeper
BRTX:NASDAQ
BioRestorative Therapies Inc
US$ १.५०
-५.६६%
(-०.०९०) 1D
US$ १.४८
-१.३३% (-०.०२०)
Pre-market
Closed: अक्टोबर १४, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BRTX...
Open
US$ १.५०
High
US$ १.५६
Low
US$ १.४२
Mkt. cap
२०.७२ लाख
Avg. vol.
१.९७ लाख
Volume
१४१.००
52-wk high
US$ ३४.४०
52-wk low
US$ १.४२
EPS
-US$ २१.७६
Beta
०.८५
Shares outstanding
१३.८१ लाख
No. of employees
१४
Open
US$ १.५०
High
US$ १.५६
Low
US$ १.४२
Mkt. cap
२०.७२ लाख
Avg. vol.
१.९७ लाख
Volume
१४१.००
52-wk high
US$ ३४.४०
52-wk low
US$ १.४२
EPS
-US$ २१.७६
Beta
०.८५
Shares outstanding
१३.८१ लाख
No. of employees
१४
News stories
From web sources and news partners
Mining Weekly
Mining Weekly
·
३७ मिनेट पहिले
Metal power producer Amaero announces $20m IPO on Nasdaq
Simply Wall Street
Simply Wall Street
·
३ मिनेट पहिले
When Can We Expect A Profit From Atossa Therapeutics, Inc. (NASDAQ:ATOS)?
Bloomberg.com
Bloomberg.com
·
१२ घण्टा पहिले
Stocks Slide as AI Rout Drives Investors to Bonds: Markets Wrap
About BioRestorative Therapies Inc
CEO-
Employees१४
Founded१९९७
Headquarters-
Sector-
Analyst ratings
Based on 1 analyst giving stock ratings to BRTX in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for BRTX in the last 3 months
Highest
Current US$ १.५०
(-१००.००%)
Average
(-१००.००%)
Lowest
(-१००.००%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Okunewitch
Maxim Group
Hold
Downgraded
-
-
10/06/2026
Jonathan Aschoff
Roth MKM
Buy
Maintained
US$ १५.००
+९००%
04/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
३.०३ लाख
११.८० हजार
१९.६० हजार
२३.१७ हजार
Cost of goods sold
८.७३ हजार
१०.५७ हजार
१.६४ हजार
७.३८ हजार
Cost of revenue
८.७३ हजार
१०.५७ हजार
१.६४ हजार
७.३८ हजार
Research and development expenses
२२.२६ लाख
२५.९५ लाख
२६.२७ लाख
१९.२६ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१३.७४ लाख
११.१५ लाख
१२.१६ लाख
१४.७५ लाख
Operating expense
३६.०० लाख
३७.१० लाख
३८.४३ लाख
३४.०२ लाख
Total operating expenses
३६.०९ लाख
३७.२१ लाख
३८.४५ लाख
३४.०९ लाख
Operating income
-३३.०५ लाख
-३७.०९ लाख
-३८.२५ लाख
-३३.८६ लाख
Other non operating income
५.७५ लाख
६.१३ लाख
५.८३ लाख
१२.२६ लाख
EBT including unusual items
-२६.५६ लाख
-३०.३८ लाख
-३२.०८ लाख
-२१.५४ लाख
EBT excluding unusual items
-२६.५६ लाख
-३०.३८ लाख
-३२.०८ लाख
-२१.५४ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-२६.५६ लाख
-३०.३८ लाख
-३२.०८ लाख
-२१.५४ लाख
Net profit margin
-८७५.७९%
-२५,७४८.११%
-१६,३६५.४९%
-९,२९८.२५%
Earnings per share
-६.००
-६.६०
-६.४०
-२.४०
Interest and investment income
७३.९२ हजार
५७.७४ हजार
३४.५९ हजार
५.४८ हजार
Interest expense
-
-
-
-
Net interest expenses
७३.९२ हजार
५७.७४ हजार
३४.५९ हजार
५.४८ हजार
Depreciation and amortization charges
-
-
-
-
EBITDA
-३२.५३ लाख
-३६.५६ लाख
-३७.७२ लाख
-३३.३३ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू